These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 9593147

  • 1. Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam.
    Ma L, Ishii Y, Ishiguro M, Matsuzawa H, Yamaguchi K.
    Antimicrob Agents Chemother; 1998 May; 42(5):1181-6. PubMed ID: 9593147
    [Abstract] [Full Text] [Related]

  • 2. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.
    Ishii Y, Ohno A, Taguchi H, Imajo S, Ishiguro M, Matsuzawa H.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2269-75. PubMed ID: 8619581
    [Abstract] [Full Text] [Related]

  • 3. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
    Silva J, Aguilar C, Ayala G, Estrada MA, Garza-Ramos U, Lara-Lemus R, Ledezma L.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):997-1003. PubMed ID: 10722503
    [Abstract] [Full Text] [Related]

  • 4. Characterization of cefotaxime-resistant Escherichia coli isolates from a nosocomial outbreak at three geriatric hospitals.
    Ma L, Matsuo H, Ishii Y, Yamaguchi K.
    J Infect Chemother; 2002 Jun; 8(2):155-62. PubMed ID: 12111569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
    Papanicolaou GA, Medeiros AA, Jacoby GA.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB, Carias LL, Bonomo RA, Shlaes DM.
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [Abstract] [Full Text] [Related]

  • 11. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
    Helfand MS, Bethel CR, Hujer AM, Hujer KM, Anderson VE, Bonomo RA.
    J Biol Chem; 2003 Dec 26; 278(52):52724-9. PubMed ID: 14534312
    [Abstract] [Full Text] [Related]

  • 12. In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Ripoll A, Baquero F, Novais A, Rodríguez-Domínguez MJ, Turrientes MC, Cantón R, Galán JC.
    Antimicrob Agents Chemother; 2011 Oct 26; 55(10):4530-6. PubMed ID: 21788458
    [Abstract] [Full Text] [Related]

  • 13. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme.
    Rasmussen BA, Keeney D, Yang Y, Bush K.
    Antimicrob Agents Chemother; 1994 Sep 26; 38(9):2078-85. PubMed ID: 7811022
    [Abstract] [Full Text] [Related]

  • 14. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
    Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH.
    Antimicrob Agents Chemother; 1993 May 26; 37(5):939-46. PubMed ID: 8517720
    [Abstract] [Full Text] [Related]

  • 15. Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca.
    Fournier B, Roy PH.
    Antimicrob Agents Chemother; 1997 Aug 26; 41(8):1641-8. PubMed ID: 9257734
    [Abstract] [Full Text] [Related]

  • 16. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA, Rudin SA, Shlaes DM.
    FEMS Microbiol Lett; 1997 Mar 01; 148(1):59-62. PubMed ID: 9066111
    [Abstract] [Full Text] [Related]

  • 17. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.
    Danel F, Hall LM, Gur D, Livermore DM.
    Antimicrob Agents Chemother; 1997 Apr 01; 41(4):785-90. PubMed ID: 9087490
    [Abstract] [Full Text] [Related]

  • 18. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S, Kuzucu Ç, Otlu B, Yetkin F, Ersoy Y.
    Mikrobiyol Bul; 2015 Jan 01; 49(1):15-25. PubMed ID: 25706727
    [Abstract] [Full Text] [Related]

  • 19. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain.
    Sabaté M, Tarragó R, Navarro F, Miró E, Vergés C, Barbé J, Prats G.
    Antimicrob Agents Chemother; 2000 Jul 01; 44(7):1970-3. PubMed ID: 10858363
    [Abstract] [Full Text] [Related]

  • 20. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR, Hujer AM, Helfand MS, Bonomo RA.
    FEMS Microbiol Lett; 2004 May 01; 234(1):99-103. PubMed ID: 15109726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.